Market closed

Genelux Corporation/$GNLX

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Genelux Corporation

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.

Ticker

$GNLX
Trading on

Industry

Biotechnology

Employees

25

GNLX Metrics

BasicAdvanced
$93M
-
-$0.95
-0.39
-
$93M
-0.39
$4.74
$2.35
4.57
4.476
5.858
7.11
-63.28%
-130.58%
9,842.52
3.26
3.26
-3.639
-95.29%
-18.01%
-19.39%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $GNLX

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs

What’s the current market cap for Genelux Corporation stock?

Genelux Corporation (GNLX) has a market cap of $93M as of April 05, 2025.

What is the P/E ratio for Genelux Corporation stock?

The price to earnings (P/E) ratio for Genelux Corporation (GNLX) stock is 0 as of April 05, 2025.

Does Genelux Corporation stock pay dividends?

No, Genelux Corporation (GNLX) stock does not pay dividends to its shareholders as of April 05, 2025.

When is the next Genelux Corporation dividend payment date?

Genelux Corporation (GNLX) stock does not pay dividends to its shareholders.

What is the beta indicator for Genelux Corporation?

Genelux Corporation (GNLX) has a beta rating of -0.39. This means that it has an inverse relation to market volatility.